MAPT and Alzheimer disease: We found DYRK1A inhibition was also able to suppress the shortened life associated with pan-neuronal overexpression of AD-associated Tau or Aβ42, again this was only a partial rescue with the treated flies living longer than their equivalent untreated genotype control but not as long as completely normal flies.